Patented Medicine Prices Review Board Risks Harming the Health of Canadians by Reducing Access to New Medicines
- Written by Newsfile
Ottawa, Ontario--(Newsfile Corp. - June 23, 2021) - On June 21, Innovative Medicines Canada (IMC) submitted six recommendations to the federal government as part of the Patented Medicine Prices Review Board's (PMPRB) Guideline Monitoring and Evaluation Plan consultations. IMC firmly maintains that industry is prepared to consult and collaborate...